Is Evogene Ltd. overvalued or undervalued?
As of August 31, 2022, Evogene Ltd. is considered overvalued and "risky," with unfavorable valuation metrics including a negative Price to Book Value of -2.01, a P/E ratio of -0.6091, and a significant stock decline of 78.20% over the past year, despite a high ROCE of 174.95%.
As of 31 August 2022, Evogene Ltd. has moved from a grade of "does not qualify" to "risky." The company is currently overvalued, as indicated by its negative Price to Book Value of -2.01 and an EV to Sales ratio of -0.27. Additionally, the EV to EBITDA stands at 0.09, suggesting that the company's valuation metrics are not favorable compared to its peers.In comparison to its peers, Evogene Ltd. has a P/E ratio of -0.6091 and an EV to EBITDA of -0.0647, which highlights its underperformance relative to the industry. Notably, while the company has a high ROCE of 174.95%, the negative return on equity reflects significant financial challenges. Over the past year, Evogene's stock has declined by 78.20%, contrasting sharply with the S&P 500's gain of 10.26%, further reinforcing the notion that the company is overvalued.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
